CD8A and neoplasm: Mechanistically, they showed that co-transfer of Th17 cells with Tc17 cells-mediated robust and long-lived anti-tumour immunity, consistent with previous publications, which showed that Th17 cells can augment the activation of CD8+ T-cells [60, 61].